This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hyundai Pharm Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hyun-Ho Yoon: Innovator in GLP-1 Receptor Agonist Development
Introduction
Hyun-Ho Yoon is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target GLP-1 receptors. His work is crucial for advancing treatments for diseases associated with GLP-1 activity.
Latest Patents
Hyun-Ho Yoon holds a patent for a GLP-1 receptor agonist. The invention relates to a compound represented by Formula 1, wherein A, B, L, X, and R are defined as described in the patent documentation. This compound, or a pharmaceutically acceptable salt thereof, serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of diseases associated with GLP-1 activity. He has 1 patent to his name.
Career Highlights
Hyun-Ho Yoon is currently employed at Hyundai Pharm Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His expertise in GLP-1 receptor agonists positions him as a key player in the development of new therapeutic options.
Collaborations
Some of his notable coworkers include Han Kyu Lee and Jeong-Un Hwang. Their collaborative efforts enhance the research and development capabilities at Hyundai Pharm Co., Ltd.
Conclusion
Hyun-Ho Yoon's work in the field of GLP-1 receptor agonists exemplifies the impact of innovative research in pharmaceuticals. His contributions are paving the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile